Reporting owner · CIK 0001852129

Callos Andrew

Visual SEC Form 4 history across 1 companies, 34 transactions and 12 filings.

EVP, CCOEVP, Chief Commercial OfficerCYTOKINETICS INC
Open-market mix
Latest filingAug 31, 2026, 08:57 PM
Filings12Form 4 records
Buying$00 purchases
Selling$5.3M14 sales
Net value−$5.3MBuys minus sells
Companies13 securities
Most recentAug 31, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-101Mar 253Jan 262Feb 267Mar 261Aug 26

Net value flow

Buys minus sells

Mar 25
−$144.6K
Jan 26
−$1M
Feb 26
−$984K
Mar 26
−$2.5M
Aug 26
−$702.4K

Transaction texture

Ownership and ticket size

Average P/S size$378.8K
Median P/S size$169K
Direct34
Indirect0
Aug 31, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern8Derivative Transactionfiling-context10Direct Ownershipfiling-context34Large Holdings Increaseholdings3Large Holdings Reductionholdings5Large Salesize6Repeat Sellerpattern11

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at CYTOKINETICS INC on Aug 31, 2026 valued at $702,400.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Associated companies

Visual map of known reporting history

CYTKCYTOKINETICS INC34 transactions · latest Aug 31, 2026, 08:57 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
CYTKCallos Andrew
EVPCCO
exercise10.0k$0M
Derivative Transaction Direct Ownership
0.0%08/3108/31
CYTKCallos Andrew
EVPCCO
sale10.0k-$70.2MS
Cluster Selling Direct Ownership Large Sale
0.0%08/3108/31
CYTKCallos Andrew
EVPCCO
exercise10.0k$23.2MM
Direct Ownership
0.0%08/3108/31
CYTKCallos Andrew
EVPCCO
sale2.91k-$18.1MS
Cluster Selling Direct Ownership Repeat Seller
+20.9%03/1803/17
CYTKCallos Andrew
EVPCCO
sale5.62k-$34.9MS
Cluster Selling Direct Ownership Large Sale+1
+20.9%03/1803/17
CYTKCallos Andrew
EVPCCO
grant29.4k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
+14.9%03/1703/15
CYTKCallos Andrew
EVPCCO
grant1.66k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
+14.9%03/1703/15
CYTKCallos Andrew
EVPCCO
grant13.3k$0A
Direct Ownership
+14.9%03/1703/15
CYTKCallos Andrew
EVPCCO
grant20.6k$0A
Direct Ownership Large Holdings Increase
+14.9%03/1703/15
CYTKCallos Andrew
EVPCCO
sale1.70k-$10.4MS
Cluster Selling Direct Ownership Repeat Seller
+15.3%03/1603/16

Callos Andrew Insider Activity FAQ

SEC Form 4 context

Who is Callos Andrew?

Callos Andrew is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001852129.

Which companies has Callos Andrew reported transactions for?

CYTOKINETICS INC

When was Callos Andrew's latest insider buy?

No open-market insider purchase is available for this period.

When was Callos Andrew's latest insider sale?

sale at CYTOKINETICS INC on Aug 31, 2026 valued at $702,400.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.